DSM opens new Dutch biotechnology centre

By Nathan Gray

- Last updated on GMT

DSM opens new Dutch biotechnology centre

Related tags Dsm managing board Nutrition Snack

Global food and nutritional ingredients supplier DSM continues its €100 million investment in R&D with the opening of a new biotechnology facility near its Delft HQ for food.

The centre will help DSM to boost biotechnology research and development capabilities for applications in food and nutrition, feed, fuel, pharma and bio-based materials, says the company.

The facility – located in Delft, near an existing fermentation pilot plant and production sites for antibiotic intermediates, yeast extracts and flavours – will bring together a wide range of biotech specialisations into one cluster innovation that houses more than 400 R&D staff, it added.

Feike Sijbesma, CEO and chairman of the DSM Managing Board, commented that the biotechnology centre will help to create solutions for societal challenges: “such as the need to provide all people globally with nutritious food, as well as enabling the transformation from a fossil-based to a bio-renewable-based society.”

Innovations currently under development in the new unit include the production of fermented steviol glycosides — the sweet-tasting molecules in the stevia plant – and a new technology that turns an inedible by-product of rapeseed agriculture into valuable plant protein for a range of uses in food.

Related news

Follow us

Products

View more

Webinars